Novartis AG
CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Last updated:
Abstract:
The invention provides immune effector cells (for example, T cells, NK cells) that express a chimeric antigen receptor (CAR), and compositions and methods thereof.
Status:
Application
Type:
Utility
Filling date:
25 Nov 2020
Issue date:
22 Jul 2021